Paladin

Nice high level summary. In addition, don't lose sight of the fact that ABL passed all required safety checks and is therefore deemed to be safe as a result of the P3 trial.  

Lastly it's an orally administered drug as well and therefore offers and inexpensive and patient-friendly treatment solution relatively speaking compared to other potential alternatives.  

So these are other high level and important derisking factors to add to your summary that would be important to a potential partner or acquirer in my opinion.

10BagR